Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

GCK anticorps

GCK Reactivité: Humain ELISA Hôte: Souris Monoclonal 4G6 unconjugated
N° du produit ABIN969172
  • Antigène Voir toutes GCK Anticorps
    GCK (Glucokinase (Hexokinase 4) (GCK))
    Reactivité
    • 50
    • 21
    • 12
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 46
    • 8
    Souris
    Clonalité
    • 49
    • 5
    Monoclonal
    Conjugué
    • 37
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp GCK est non-conjugé
    Application
    • 45
    • 24
    • 24
    • 9
    • 6
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    ELISA
    Fonction
    GCK Antibody
    Purification
    Ascitic fluid
    Immunogène
    Purified recombinant fragment of human GCK expressed in E. Coli.
    Clone
    4G6
    Isotype
    IgG1
    Top Product
    Discover our top product GCK Anticorps primaire
  • Indications d'application
    ELISA: 1/10000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Barbetti, Cobo-Vuilleumier, Dionisi-Vici, Toni, Ciampalini, Massa, Rodriguez-Bada, Colombo, Lenzi, Garcia-Gimeno, Bermudez-Silva, Rodriguez de Fonseca, Banin, Aledo, Baixeras, Sanz, Cuesta-Muñoz: "Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene." dans: Molecular endocrinology (Baltimore, Md.), Vol. 23, Issue 12, pp. 1983-9, (2009) (PubMed).

    Yoshida, Kato, Yokoi, Oguri, Watanabe, Metoki, Yoshida, Satoh, Aoyagi, Nishigaki, Nozawa, Yamada: "Association of genetic variants with chronic kidney disease in individuals with different lipid profiles." dans: International journal of molecular medicine, Vol. 24, Issue 2, pp. 233-46, (2009) (PubMed).

  • Antigène
    GCK (Glucokinase (Hexokinase 4) (GCK))
    Autre désignation
    GCK (GCK Produits)
    Sujet

    Description: Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. Alternative splicing of this gene results in three tissue-specific forms of glucokinase, one found in pancreatic islet beta cells and two found in liver. The protein localizes to the outer membrane of mitochondria. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. Mutations in this gene have been associated with non-insulin dependent diabetes mellitus (NIDDM), maturity onset diabetes of the young, type 2 (MODY2) and persistent hyperinsulinemic hypoglycemia of infancy (PHHI).

    Aliases: GK, GLK, HK4, HHF3, HKIV, HXKP, LGLK, MODY2, FGQTL3

    Poids moléculaire
    52kDa
    ID gène
    2645
    HGNC
    2645
    UniProt
    P35557
    Pathways
    Signalisation MAPK, Positive Regulation of Peptide Hormone Secretion, Carbohydrate Homeostasis, Cellular Glucan Metabolic Process, Regulation of Carbohydrate Metabolic Process
Vous êtes ici:
Support technique